Literature DB >> 12573278

Alternatively spliced FGFR-1 isoform signaling differentially modulates endothelial cell responses to peroxynitrite.

Jing Jiao1, Jessica S Greendorfer, Pei Zhang, Kurt R Zinn, Clement A Diglio, John A Thompson.   

Abstract

Mounting experimental evidence has suggested that the trophic environment of cells in culture is an important determinant of their vulnerability to the cytotoxic effects of reactive oxidants such as peroxynitrite (ONOO(-)). However, acidic fibroblast growth factor (FGF-1)-induced signaling renders some cells more sensitive and others resistant to the cytotoxic effects of ONOO(-). To determine whether alternatively spliced fibroblast growth factor receptor (FGFR-1) isoforms are responsible for this differential response, we have stably transfected FGFR-negative rat brain-derived resistant vessel endothelial cells (RVEC) with human cDNA sequences encoding either FGFR-1 alpha or FGFR-1 beta. FGF-1 treatment of RVEC(R-1 alpha) transfectants enhanced ONOO(-)-mediated cell death in a manner dependent upon FGFR-1 tyrosine kinase, MEK/Erk 1/2 kinase, and p38 MAP kinase activities and independent of Src-family kinase (SFK) activity. FGF-1 treatment of RVEC(R-1 beta) transfectants inhibited the cytotoxic effects of ONOO(-) in a manner dependent upon FGFR-1 tyrosine kinase, MEK/Erk 1/2 kinase, and SFK activities and independent of p38 MAP kinase activity. FGF-1-induced preactivation of both FGFR-1 tyrosine and Erk 1/2 kinases was detected in both RVEC(R-1 alpha) and RVEC(R-1 beta) transfectants. FGF-1-induced preactivation of p38 MAPK was restricted to RVEC(R-1 alpha) transfectants, whereas, ligand-induced preactivation of SFK was limited to RVEC(R-1 beta) transfectants. Collectively, these results both reemphasize the role of extracellular trophic factors and their receptor-mediated signaling pathways during cellular responses to oxidant stress and provide a first indication that the alternatively spliced FGFR-1 isoforms induce differential signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573278     DOI: 10.1016/s0003-9861(02)00681-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells.

Authors:  Ming Zhao; Ming-Lei Zhuo; Xiaofeng Zheng; Xiaoping Su; Funda Meric-Bernstam
Journal:  Oncotarget       Date:  2019-01-01

2.  Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays.

Authors:  Katerina Kechris; Yee Hwa Yang; Ru-Fang Yeh
Journal:  BMC Genomics       Date:  2008-11-20       Impact factor: 3.969

Review 3.  A Network Map of FGF-1/FGFR Signaling System.

Authors:  Rajesh Raju; Shyam Mohan Palapetta; Varot K Sandhya; Apeksha Sahu; Abbas Alipoor; Lavanya Balakrishnan; Jayshree Advani; Bijesh George; K Ramachandra Kini; N P Geetha; H S Prakash; T S Keshava Prasad; Yu-Jung Chang; Linyi Chen; Akhilesh Pandey; Harsha Gowda
Journal:  J Signal Transduct       Date:  2014-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.